Results 171 to 180 of about 27,780 (214)

Systematic Review and Meta-Analysis of Clinical Efficacy and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections. [PDF]

Int J Mol Sci
Bucataru A, Turcu-Stiolica A, Calina D, Balasoiu AT, Zlatian OM, Osman A, Balasoiu M, Ghenea AE.   +7 more
europepmc   +1 more source

Risk Factors and Molecular Epidemiology of Infections Among Patients with Intestinal Colonization by Carbapenem-Resistant <i>Enterobacteriaceae</i>: A Retrospective Study of Active Screening in a Tertiary Hospital. [PDF]

Infect Drug Resist
Li X, Huang M, Shan B, Zhu X, Xu Y, Li S, Li X, Zheng X, Dong Y, Zhang H.   +9 more
europepmc   +1 more source

MOLECULAR EPIDEMIOLOGY OF MULTI-DRUG RESISTANT Acinetobacter baumannii IN INTENSIVE CARE UNITS OF MULTIPLE SOUTH EUROPEAN HOSPITALS [PDF]

, 2009
Giannouli, Maria
core  

Epidemiology and resistance mechanisms of tigecycline- and carbapenem-resistant <i>Enterobacteriaceae</i> in China: a multicentre genome-based study. [PDF]

Front Microbiol
Yan L, Ma T, Wang W, Cai Z, Du H, Chen Z, Han R, Guo Y, Li G, Jia W, Tao J.   +10 more
europepmc   +1 more source

Ceftazidime-avibactam versus polymyxins in treating patients with carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis. [PDF]

Infection
Chen J, Hu Q, Zhou P, Deng S.
europepmc   +1 more source